Orderable Name IBDP2 Inflammatory Bowel Disease Serology Panel, Serum
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL Serum
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Useful For
Distinguishing between ulcerative colitis and Crohn disease in patients for whom the specific diagnosis is unclear based on endoscopic, pathologic, and imaging evaluations
This test is not useful for determining the extent of disease in patients with inflammatory bowel disease or determining the response to disease-specific therapy including surgical resection of diseased intestine.
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| ANCA2 | Cytoplasmic Neutrophilic Ab IBD, S | No | Yes |
| SCERA | Saccharomyces cerevisiae Ab, IgA, S | Yes | Yes |
| SCERG | Saccharomyces cerevisiae Ab, IgG, S | Yes | Yes |
Method Name
ANCA2: Indirect Immunofluorescent Assay (IFA)
SCERA, SCERG: Enzyme-Linked Immunosorbent Assay (ELISA)
Specimen Type
SerumSpecimen Minimum Volume
Serum: 0.8 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 21 days |
| Frozen | 21 days |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | Reject |
| Gross icterus | OK |
| Heat-treated specimen | Reject |
Reference Values
CYTOPLASMIC NEUTROPHIL ANTIBODIES, INFLAMMATORY BOWEL DISEASE PANEL, SERUM
Negative (not detectable)
SACCHAROMYCES CEREVISIAE ANTIBODY, IGA
Negative: <20.0 RU/mL
Positive: ≥20.0 RU/mL
SACCHAROMYCES CEREVISIAE ANTIBODY, IGG
Negative: <20.0 RU/mL
Positive: ≥20.0 RU/mL
Day(s) Performed
Monday through Friday
Report Available
3 to 7 daysCPT Code Information
86671 x 2
86036
Forms
If not ordering electronically, complete, print, and send Gastroenterology and Hepatology Test Request (T728) with the specimen.
Testing Algorithm
For more information see the following:
-Inflammatory Bowel Disease Diagnostic Testing Algorithm
-Ulcerative Colitis and Crohn Disease Therapeutic Drug Monitoring Algorithm